Seer

About Seer

Seer is a life sciences company focused on capturing deep molecular insights from the proteome to enable novel insights and breakthroughs in the understanding of biology and disease. Our novel Proteograph™ platform allows for the first-ever generation of proteomic information with high accuracy at a scale and speed not previously possible, complementing genomic and other health information, and with a goal of enabling research breakthroughs in the most challenging clinical problems, such as early disease detection. We are advancing a portfolio of first-in-class products for research and clinical applications. Our technology can be utilized in strategic partnership with other key industry players to optimize their impact on drug discovery and development.